Stocktoria

LivaNova PLC LIVN

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2015-10-19 · LEI

LivaNova PLC financials (annual)

Revenue
$964.9M $1.01B $1.11B $1.08B $934.2M $1.04B $1.02B $1.15B $1.25B $1.39B 2016201720182019202020212022202320242025
Net income
-$62.8M -$25.1M -$189.4M -$157.6M -$348.8M -$135.8M -$86.2M $17.5M $63.2M -$242.5M 2016201720182019202020212022202320242025
Free cash flow
$51.8M $58.4M $83.3M -$115.8M -$114.4M $77.1M $43.4M $39.9M $135.9M $173.3M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.4B$1.3B$1.2B$1.0B$1.0B$934.2M$1.1B$1.1B$1.0B$964.9M
Gross profit$939.9M$853.5M$755.8M$707.2M$706.0M$594.8M$723.8M$651.6M$559.5M
R&D expense$185.8M$182.5M$193.8M$155.8M$183.4M$152.9M$146.8M$145.9M$109.5M$82.1M
SG&A expense$548.8M$508.9M$502.7M$469.2M$471.9M$446.6M$528.5M$465.0M$380.1M$355.2M
Operating income$199.4M$129.1M-$68.5M-$76.8M-$784,000-$273.9M-$171.6M-$248.1M$96.5M$33.4M
Interest expense$58.9M$48.2M$50.2M$40.8M$15.1M$9.8M$7.8M$10.6M
Income tax$21.6M$25.1M-$98.9M$11.1M$11.2M-$960,000-$30.4M-$69.6M$50.0M$5.1M
Net income-$242.5M$63.2M$17.5M-$86.2M-$135.8M-$348.8M-$157.6M-$189.4M-$25.1M-$62.8M
EPS (diluted)$-4.45$1.16$0.32$-1.61$-2.68$-7.18$-3.26$-3.91$-0.52$-1.28
Operating cash flow$254.3M$183.0M$74.9M$69.9M$102.5M-$79.4M-$91.1M$120.5M$91.3M$90.2M
Free cash flow$173.3M$135.9M$39.9M$43.4M$77.1M-$114.4M-$115.8M$83.3M$58.4M$51.8M
Cash & equivalents$635.6M$428.9M$266.5M$214.2M$208.0M$252.8M$61.1M$47.2M$93.6M$39.8M
Inventory$164.7M$147.6M$147.9M$129.4M$105.8M$115.3M$164.2M$153.5M$144.5M$133.0M
Total assets$2.6B$2.5B$2.4B$2.3B$2.2B$2.4B$2.4B$2.5B$2.5B$2.3B
Total liabilities$1.4B$1.2B$1.2B$1.1B$906.3M$1.3B$1.0B$1.0B$688.6M$635.7M
Shareholders' equity$1.2B$1.3B$1.3B$1.2B$1.3B$1.1B$1.4B$1.5B$1.8B$1.7B

Growth · year-over-year · Revenue CAGR 4.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+10.7%+8.7%+12.9%-1.3%+10.8%-13.8%-2.1%+9.4%+4.9%
Net income growth-483.5%+260.4%
EPS growth-483.6%+262.5%
Free cash flow growth+27.5%+240.4%-8.0%-43.7%-239.1%+42.6%+12.8%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.